AstraZeneca AZN3.10%increase; green up pointing triangle has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell ...

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo I was in the packed hall at Davos to hear Trump speak. The audience went from laughter to silence in seconds.

AstraZeneca is aiming to more than double its portfolio of new cancer drugs by the end of this decade, seeking the top spot in the world's most lucrative category of medicines. The U.K. drugmaker ...